The Centre for Chronic Disease Control (CCDC), a non-profit organization focused on healthcare, announced the completion of a significant study on drug treatment optimization for hypertension in India on November …
Amy
Amy
Amy Scanlon, MD, FACC, is a practicing private practice cardiologist at Consultants in Cardiology and the current team cardiologist for Seton Hall University. Dr. Scanlon has authored several published articles including the American College of Cardiology’s Preparticipation Cardiovascular Screening for Adolescent and Young Adult Athletes module. He frequently lectures and participates in speaking engagements for the American Heart Association and the American College of Cardiology.
-
-
The role of inflammation in coronary artery disease has been recognized for years, but recent developments have sparked renewed interest. The FDA’s 2023 approval of colchicine, the first drug specifically …
-
At the American Heart Association’s annual scientific sessions in Chicago, both Boston Scientific and Abbott showcased studies supporting their devices designed to seal the left atrial appendage (LAA). This pocket …
-
Excess cholesterol is known to create artery-clogging plaques, which can lead to strokes, arterial disease, heart attacks, and more. This issue has become a central focus of many heart health …
-
Extreme Heat Linked to Increased Risk of Atrial Arrhythmias in Patients with Implantable Devices
by Amyby AmyNew research suggests that high temperatures significantly increase the risk of atrial arrhythmias in patients with cardiac implantable electronic devices. The study, presented by Dr. Barrak Alahmad from Harvard T.H. …
-
Eli Lilly and Company has announced promising results from its SUMMIT Phase 3 trial, which studied the effects of tirzepatide on patients with heart failure and obesity. The trial demonstrated …
-
Smartcardia SA has gained U.S. FDA clearance for its seven-lead live ECG monitoring patch and cloud platform, allowing for mobile outpatient cardiac telemetry. This innovative solution enables remote monitoring of …
-
KANSAS CITY, Mo. — St. Luke’s Mid America Heart Institute has launched a significant clinical trial this year aimed at treating patients with atrial fibrillation (Afib), a common heart rhythm …
-
Bayer has announced a new partnership with U.S. biotech company Cytokinetics to acquire rights for an experimental heart drug in Japan. This collaboration aims to strengthen Bayer’s position in the …
-
Atrial flutter is a common cardiac arrhythmia characterized by rapid and organized electrical impulses in the atria, leading to a fast heartbeat. It is particularly prevalent among the elderly population, …